Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice
- 19 May 2020
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 881, 173204
- https://doi.org/10.1016/j.ejphar.2020.173204
Abstract
No abstract availableKeywords
Funding Information
- Council of Scientific and Industrial Research, India
- University Grants Commission
- Indian Council of Medical Research (10053)
- Department of Biotechnology, Government of West Bengal
This publication has 30 references indexed in Scilit:
- Isoalantolactone derivative promotes glucose utilization in skeletal muscle cells and increases energy expenditure in db/db mice via activating AMPK-dependent signalingMolecular and Cellular Endocrinology, 2018
- Pancreastatin-Dependent Inflammatory Signaling Mediates Obesity-Induced Insulin ResistanceDiabetes, 2014
- Overexpression of Carnitine Palmitoyltransferase-1 in Skeletal Muscle Is Sufficient to Enhance Fatty Acid Oxidation and Improve High-Fat Diet–Induced Insulin ResistanceDiabetes, 2009
- Free fatty acids and insulin resistanceCurrent Opinion in Clinical Nutrition and Metabolic Care, 2007
- Exercise-Induced Phosphorylation of the Novel Akt Substrates AS160 and Filamin A in Human Skeletal MuscleDiabetes, 2006
- Ceramide Content Is Increased in Skeletal Muscle From Obese Insulin-Resistant HumansDiabetes, 2004
- Inflammation: the link between insulin resistance, obesity and diabetesTrends in Immunology, 2004
- Proteolytic processing of chromogranin A by the prohormone convertase PC2Regulatory Peptides, 2003
- Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDMDiabetes, 1997
- Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM)Regulatory Peptides, 1990